PDG16 PREDICTING THE COST-EFFECTIVENESS OF GENERIC VERSUS...

Value in Health 2019 / 05 Vol. 22

PDG16 PREDICTING THE COST-EFFECTIVENESS OF GENERIC VERSUS BRAND DABIGATRAN USING PHARMACOMETRIC ESTIMATES AMONG PATIENTS WITH ATRIAL FIBRILLATION

Wang, C.Y., Kim, S., Lingineni, K., Schmidt, S., Diaby, K., Brown, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.695
Date:
May, 2019
File:
PDF, 379 KB
english, 2019
Conversion to is in progress
Conversion to is failed